
News & Events category:
Wythenshawe, Trafford, Withington and Altrincham


MFT team recruits first UK patient to ‘OSCAR’ COVID-19 research study
The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.
Read more
MFT lung screening research among top recruiting cancer studies
Manchester University NHS Foundation Trust’s (MFT) ground-breaking qUEST research, part of the Manchester Lung Health Checks programme, has been named among the top-recruiting cancer studies in Englan
Read more
Manchester doctors play leading role in ‘breakthrough’ COVID-19 drug research
Manchester doctors have played a leading role in global coronavirus research, which has found the first drug shown to increase survival rates in people hospitalised with COVID-19.
Read more
First MFT patient receives drug ‘Anakinra’ under COVID-19 trial SCIL-1Ra
A Wythenshawe Hospital patient with COVID-19 is the first Manchester University NHS Foundation Trust recruit to a clinical trial investigating the drug Anakinra to treat COVID-19.
Read more
Children of Manchester researchers join COVID-19 antibody study
Many MFT staff members are involving their children in our vitally important COVID-19 research, with some of them sharing their experiences.
Read more
More than 600 Greater Manchester school children and teachers participate in national research monitoring prevalence of COVID-19
More than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.
Read more
First MFT patient takes part in adaptive COVID-19 trial – ‘ACCORD 2’
Our first patient has taken part in a new clinical trial investigating potential treatments for COVID-19, as part of a nationwide research effort to meet the challenge of coronavirus.
Read more